Ramanouskaya Tanya V, Smolnykova Victoria V, Grinev Vasily V
Department of Genetics, Faculty of Biology, Belarusian State University, Minsk 220030, Belarus.
Anticancer Drugs. 2009 Aug;20(7):573-83. doi: 10.1097/CAD.0b013e32832d684c.
The aim of this study was to reveal the relationships between structure elements of flavonoids and their antileukemic activity. The human leukemia cell line K562 as a model of blast crisis of chronic myeloid leukemia and a set of 18 different flavonoids from four flavonoid subfamilies were used for researching these relationships. Relationships between structure and antiproliferative, proapoptotic, and differentiation activities of flavonoids were estimated by pairwise comparative analysis of selected flavonoids that differ in one structure element. We found that C4 carbonyl and C2-C3 double bonds are critical structure elements for antileukemic activity of flavonoids. We also observed that the ortho-position of hydroxyl groups in the B ring of the flavonoid molecule has an advantage over other variants of B ring hydroxylation patterns. At the same time, flavonoids with a nonhydroxylated B ring were more effective. In the A ring, hydroxylation status of C5 is not critical for antileukemic activity of the flavonoids, whereas the appearance of the hydroxyl group in the C6 position of the flavonoid molecule significantly decreased the IC50 (inhibition concentration required for 50% cytotoxic effect) value. Glycosylation of flavonoids was associated with dramatically decreased activity. These data may help in the rational design of semisynthetic flavonoids with improved antileukemic activity.
本研究的目的是揭示黄酮类化合物的结构元素与其抗白血病活性之间的关系。使用人类白血病细胞系K562作为慢性髓性白血病急变期的模型,以及来自四个黄酮类亚家族的18种不同黄酮类化合物来研究这些关系。通过对在一个结构元素上存在差异的选定黄酮类化合物进行成对比较分析,评估黄酮类化合物的结构与抗增殖、促凋亡和分化活性之间的关系。我们发现C4羰基和C2-C3双键是黄酮类化合物抗白血病活性的关键结构元素。我们还观察到,黄酮类分子B环中羟基的邻位比B环羟基化模式的其他变体具有优势。同时,B环未羟基化的黄酮类化合物更有效。在A环中,C5的羟基化状态对黄酮类化合物的抗白血病活性并不关键,而黄酮类分子C6位出现羟基会显著降低IC50(产生50%细胞毒性作用所需的抑制浓度)值。黄酮类化合物的糖基化与活性显著降低有关。这些数据可能有助于合理设计具有更高抗白血病活性的半合成黄酮类化合物。